Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer
Ryan J. Hartmaier(Magee-Womens Research Institute), Sally E. Trabucco(Foundation Medicine (United States)), Nolan Priedigkeit(Magee-Womens Research Institute), Jon Chung(Foundation Medicine (United States)), Christine A. Parachoniak(Foundation Medicine (United States)), Pierre Vanden Borre(Foundation Medicine (United States)), Samantha Morley(Foundation Medicine (United States)), Mark R. Rosenzweig(Foundation Medicine (United States)), Laurie M. Gay(Foundation Medicine (United States)), Michael E. Goldberg(Foundation Medicine (United States)), James Suh(Foundation Medicine (United States)), Siraj M. Ali(Foundation Medicine (United States)), Jeffrey S. Ross(Foundation Medicine (United States)), Brian Leyland‐Jones(Avera Health), Brandon Young(Avera Health), Casey Williams(Avera Health), B. Park(Sidney Kimmel Comprehensive Cancer Center), Meng‐Chen Tsai(Minnesota Oncology), Barbara Haley(Southwestern Medical Center), Julio A. Peguero(Hematology Oncology Consultants), Rena D. Callahan(UCLA Medical Center), Irina Sachelarie(Regional Medical Center), J. Cho(CancerCare), Jennifer M. Atkinson(Magee-Womens Research Institute), Amir Bahreini(Isfahan University of Medical Sciences), Alison M. Nagle(Magee-Womens Research Institute), Shannon L. Puhalla(Avera Health), Rebecca Watters(University of Pittsburgh), Zeynep Erdogan-Yildirim(University of Pittsburgh), Lan Cao(Central South University), Steffi Oesterreich(Magee-Womens Research Institute), Aju Mathew(University of Pittsburgh), Peter C. Lucas(University of Pittsburgh), Nancy E. Davidson(Avera Health), Adam Brufsky(Avera Health), Garrett M. Frampton(Foundation Medicine (United States)), Philip J. Stephens(Foundation Medicine (United States)), Juliann Chmielecki(Foundation Medicine (United States)), A.V. Lee(Magee-Womens Research Institute)
Cited by 106Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis